|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
10 months to Dec 31, 2021
|
|
|---|---|---|---|
| Revenues | |||
| Cost of revenues | |||
| Gross profit (loss) | |||
| Operating expenses: | |||
| Research and development | |||
| Selling, general and administrative | |||
| Total operating expenses | |||
| Operating loss | |||
| Interest earned on marketable securities held in Trust Account | |||
| Other income (expense): | |||
| Other income | |||
| Interest expense | |||
| Change in estimated fair value of earn-out liabilities | |||
| Total other income | |||
| Loss before income taxes | |||
| Income tax expense | |||
| Net loss | |||
| Common Class A | |||
| Common Class B | |||
| Total net loss | |||
| Unrealized gain (loss) on short-term investments | |||
| Comprehensive loss | |||
| Basic and diluted weighted average shares outstanding | |||
| Common Class A | |||
| Common Class B | |||
| Basic and diluted net loss per share | |||
| Dividends on Series D convertible preferred stock | |||
| Redemption value of Series D convertible preferred stock | |||
| Net loss attributable to common stockholders - basic | |||
| Net loss per share attributable to common stockholders - basic | |||
| Net loss per share attributable to common stockholders - diluted | |||
| Weighted average common stock outstanding - basic | |||
| Weighted average common shares outstanding - diluted |
Loading...